Why the study?
What is the role of monocytes in heart failure, and should monocyte activation be considered a therapeutic target?
What is the role of monocytes in heart failure, and should monocyte activation be considered a therapeutic target?
This review highlights the dual role of monocytes in heart failure, suggesting that promoting their tissue repair functions could be a novel therapeutic strategy.
Authors
No takes yet. Share an insight, caveat, or question.
Does not support altering monocyte therapies in HF practice; leaves open activation strategies for prospective trials.
Apostolakis et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: